Large-scale testing (Phase 3)Study completedNCT05958407
What this trial is testing
A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
Who this might be right for
Atopic DermatitisAtopic Hand Eczema
LEO Pharma 235